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O
ver the past 2 decades, systematic reviews have risen
in number, quality, and impact. The sheer volume of
work is remarkable. For example, the annual number of
meta-analyses (a subset of systematic reviews) indexed by
MEDLINE has grown from 273 in 1990 to 4,526 in 2010.
Well-conceived and written systemic reviews serve many
functions for stakeholders. First, they help clinicians apply
evidence from the medical literature to patient care by
critically appraising and summarizing what is often, for a
given topic, a large amount of published clinical investiga-
tion. Systematic reviews are particularly useful when
substantial practice variation exists, actual practice differs
from published standards of care, clinical guidelines differ in
their recommendations, and a large body of recent literature
provides new insights that may modify recommendations
from those of published guidelines.
Second, they can provide the basis for establishing and
revising clinical guidelines as well as many quality assess-
ment metrics applied to physicians, group practices, and
hospitals. Third, they can inform future research agendas by
defining important unresolved questions. Lastly, they draw
attention to differences in findings across studies addressing
similar research questions and propose a basis for the
conflicting results. For all of these reasons, their impact can
be substantial. For example, in one study of 170 journals in
the fields of general internal medicine, family practice,
nursing, and mental health, the average impact factor for
systematic reviews was 26.5.
1 In contrast, the mean impact
factor for the top 40 general medical journals is 7.4.
Guidelines to assist authors of systematic reviews in
medicine have evolved. Published in 1999, the QUORUM
(Quality of Reporting of Meta-analyses) guideline for
reporting systematic reviews
2 aimed to standardize and
improve published reports of systematic reviews. Subse-
quent evolution of review methods, including increasingly
rigorous assessments of the risk of bias and more frequent
inclusion of observational data, prompted the development
of an updated reporting tool, PRISMA (Preferred Reporting
Items for Systematic Reviews and Meta-Analyses), which
was published in 2009.
3,4 PRISMA aims to standardize the
reporting of systematic reviews; it offers less guidance to
authors on the conduct and performance of such reviews.
Guidelines also exist to assist authors in the conduct of
reviews. Since 1994, the Cochrane Collaboration has pub-
lished, and regularly updated, a detailed handbook for authors
of systematic reviews.
5 This methods guide focuses primarily
on reviews of randomized controlled trials of interventions.
While developed for authors of Cochrane reviews, the
handbook is freely available and has been a helpful resource
for other authors of systematic reviews.
One mission of the Agency for Healthcare Research and
Quality (AHRQ) is to solicit and publish systematic reviews
(evidence reports and technology assessments) on topics to
improve the clinical practice and delivery of health-care
services. In 1997, AHRQ formed the Evidence-based
Practice Center (EPC) Program to commission and oversee
these reviews.
6 One of us (SC) directs the EPC program
under the umbrella of the Center for Outcomes and Evidence,
and one (DM) directed the Duke EPC. EPCs conduct reviews
for use by a variety of groups, including national guideline
groups, such as the US Preventive Services Task Force
(USPSTF),
7 which uses reviews to inform screening and
prevention guidelines, and payers, such as the Centers for
Medicare and Medicaid Services. To improve the quality and
consistency of EPC reports, the Agency has published
methods guidance, developed by EPC authors (Methods
Guide for Effectiveness and Comparative Effectiveness
JGIM
S1Reviews).
8 This guidance, along with those of other groups
such as the Cochrane Collaboration, the USPSTF,
9 and the
Institute of Medicine
10, forms the basis for a standards in the
conduct of systematic reviews.
The editors of the AHRQ Methods Guide realized, however,
that systematic reviews of medical tests pose unique
challenges that are not adequately addressed in guidelines
for authors of reviews of interventions or comparative
efficacy. For example, the principle “outcome” of a study of
a medical test is commonly a proxy or intermediate outcome.
An illustration of this is ultrasound evaluation of the carotid
arteries. The most common outcome in an evaluation of this
test is the accuracy of the test in identifying clinically
significant stenosis of the artery. Clinicians, while interested
in this proxy outcome, would find more value in the ability of
the test to predict clinically significant outcomes (such as 10-
year risk of stroke or cardiovascular death) or the effect of
subsequent carotid endarterectomy or stenting on stroke or
death rates. A review of the operating characteristics of
carotid ultrasound would optimally assess both the proxy
result (as compared to a reference standard, in this case,
invasive angiography) and the downstream result of testing on
clinically significant outcomes.
Clinicians obtain medical tests for a number of non-
overlapping reasons. These include screening, diagnosis,
prognosis, and prediction of treatment response. In recogni-
tion of the unique challenges in conducting reviews of
diagnostic tests, the Cochrane Collaboration has formed a
working group specifically tasked with providing guidance in
this arena. A draft version of their handbook, which is at
present incomplete, has begun to address these challenges.
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AHRQ has also recognized the limitations of the Methods
Guide for Effectiveness and Comparative Effectiveness
Reviews (herein referred to as the General Methods Guide)
when applied to studies of medical tests. In 2007, AHRQ
convened an expert working meeting on the methodologic
challenges in performing systematic reviews of medical
tests. Four white papers were commissioned and presented
on May 28–29, 2008.
12 The discussions from this meeting
formed the basis for the Medical Test EPC workgroups, led
by DM, then director of the Center for Clinical Health
Policy Research and of the Duke EPC. Three EPC work-
groups identified and addressed practical challenges in each
step of conducting systematic reviews of medical tests
(understanding the context, performing the review, and
synthesizing the evidence). From these workgroups, EPC
authors wrote nine draft papers providing guidance on steps
for systematically reviewing medical test evidence that were
either not covered in the existing General Methods Guide or
that illustrated how to apply the General Methods Guide to
medical test evaluation. An additional two workgroups
addressed issues unique to genetic and prognostic tests.
Each paper underwent extensive peer review by EPC
investigators, external peer review, and public comment.
The Society of General Internal Medicine (SGIM) and the
editorial leadership of the Journal of General Internal
Medicine recognize that academic general internists share
with AHRQ the desire to improve the quality of systematic
reviews of medical tests through dissemination of methods
guides to potential authors. AHRQ approached the Journal’s
editorial leadership and proposed a collaborative effort to
review and publish this guide. The AHRQ Scientific
Resource Center managed the peer and public review process
through the usual Effective Health Care Program mecha-
nisms. Two deputy editors from the Journal (GS and CU)
reviewed the peer and public review comments, and author
responses. All four of us reconciled any remaining issues and
submitted a consensus letter to the corresponding author of
each chapter with additional requests for revisions. In
particular, we sought to expand the scope of the articles
beyond EPC authors to provide relevant guidance to all
authors of systematic reviews of medical tests. Likewise, we
guided manuscript development so that the resulting chapters
would be of value to readers of systematic reviews of
medical tests who seek to determine the strengths and
weaknesses of the review and its impact on clinical practice.
We asked authors to identify potential differences between
their chapters and the recommendations from the upcoming
Cochrane handbook for systematic reviews of diagnostic test
accuracy, and to comment on the basis for any disparities.
The final versions of each chapter manuscript were submitted
simultaneously to the Journal for typesetting and to AHRQ for
public posting. AHRQ also developed online training modules
for authors based on the content of these manuscripts.
13
This supplement represents the final product of these
efforts. The supplement covers 12 core aspects of the optimal
conduct of systematic reviews of medical tests and serves as
guidance for authors. However, each paper, or chapter, stands
on its own. It is our sincere hope that EPC and non-ECP
authors of systematic reviews, as well as other researchers
and clinician readers, will find this collated Methods Guide
for Systematic Reviews of Medical Tests to be helpful for the
generation and appraisal of reviews, as well as the application
of reviews to decision making about the use of specific
medical tests in clinical practice.
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